tiprankstipranks
Australian Dairy Nutritionals Group (AU:AHF)
ASX:AHF
Want to see AU:AHF full AI Analyst Report?

Australian Dairy Nutritionals Group (AHF) AI Stock Analysis

9 Followers

Top Page

AU:AHF

Australian Dairy Nutritionals Group

(Sydney:AHF)

Select Model
Select Model
Select Model
Neutral 42 (OpenAI - 5.2)
Rating:42Neutral
Price Target:
AU$0.02
▼(-60.00% Downside)
Action:Reiterated
Date:07/18/26
The score is primarily held back by weak financial performance: despite strong revenue growth, margins remain negative and cash flow metrics show ongoing pressure. Technical indicators are mixed-to-weak with a negative MACD and the price below longer-term moving averages. Valuation is constrained by losses (negative P/E) and the absence of a dividend yield.
Positive Factors
High revenue growth
Sustained revenue growth near mid-double digits demonstrates continuing market demand and top-line momentum. Over 2-6 months, this growth provides a foundation for scaling fixed costs, improving unit economics, and enabling management to prioritize path-to-profit initiatives if cost controls are implemented.
Negative Factors
Negative profitability margins
Persistently negative gross and net margins reflect structural profitability issues that limit free cash generation and reinvestment capacity. Without sustained margin improvement through pricing, mix, or cost reductions, the business will struggle to convert revenue growth into durable shareholder returns over coming months.
Read all positive and negative factors
Positive Factors
Negative Factors
High revenue growth
Sustained revenue growth near mid-double digits demonstrates continuing market demand and top-line momentum. Over 2-6 months, this growth provides a foundation for scaling fixed costs, improving unit economics, and enabling management to prioritize path-to-profit initiatives if cost controls are implemented.
Read all positive factors

Australian Dairy Nutritionals Group (AHF) vs. iShares MSCI Australia ETF (EWA)

Australian Dairy Nutritionals Group Business Overview & Revenue Model

Company Description
Australian Dairy Nutritionals Group operates as a fully integrated enterprise specializing in the production of dairy products throughout Australia. The company's activities are organized into two main divisions: Dairy Farms and Dairy Processing. ...
How the Company Makes Money
null...

Australian Dairy Nutritionals Group Financial Statement Overview

Summary
Revenue growth is strong (34.74%), but profitability is a major issue with negative gross, EBIT/EBITDA, and net margins. Balance sheet leverage is very low (debt-to-equity 0.002), yet returns remain weak (negative ROE). Cash flow trends are concerning with negative free cash flow growth and weak cash conversion metrics.
Income Statement
35
Negative
Balance Sheet
45
Neutral
Cash Flow
30
Negative
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue7.53M7.17M6.18M5.86M5.80M21.30M
Gross Profit-1.10M-1.42M-2.15M-288.23K-4.36M-3.27M
EBITDA-4.54M-4.30M-6.26M-5.95M-1.29M-5.34M
Net Income-4.42M-5.21M-7.36M-9.16M-4.15M-6.40M
Balance Sheet
Total Assets24.17M25.09M30.35M36.24M44.60M43.11M
Cash, Cash Equivalents and Short-Term Investments809.01K2.69M6.13M2.01M2.43M6.23M
Total Debt200.85K48.45K2.25M1.04M1.09M6.49M
Total Liabilities2.02M1.44M3.62M2.72M4.65M9.12M
Stockholders Equity22.31M23.85M26.87M33.59M16.05M33.99M
Cash Flow
Free Cash Flow-3.65M-3.46M-4.72M-7.91M-6.90M-7.11M
Operating Cash Flow-3.24M-3.28M-4.44M-7.05M-3.80M-2.03M
Investing Cash Flow-245.46K-47.59K6.73M6.18M3.10M1.07M
Financing Cash Flow-184.50K-94.51K1.80M449.98K-3.07M796.49K

Australian Dairy Nutritionals Group Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.04
Price Trends
50DMA
0.02
Negative
100DMA
0.02
Negative
200DMA
0.03
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
41.95
Neutral
STOCH
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:AHF, the sentiment is Negative. The current price of 0.04 is above the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.02, and above the 200-day MA of 0.03, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 41.95 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:AHF.

Australian Dairy Nutritionals Group Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
AU$157.81M17.8612.22%2.27%27.60%96.31%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
56
Neutral
AU$79.58M22.388.70%23.29%
51
Neutral
AU$1.87B303.000.82%1.95%1.47%-76.20%
42
Neutral
AU$12.60M-2.67-19.17%44.25%41.58%
40
Underperform
AU$13.33M-2.78-41.69%53.69%45.24%
39
Underperform
AU$6.66M-0.01226.76%-32.83%83.37%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:AHF
Australian Dairy Nutritionals Group
0.02
-0.03
-64.44%
AU:BGA
Bega Cheese Limited
6.06
0.89
17.33%
AU:BUB
Bubs Australia Ltd.
0.09
-0.08
-44.71%
AU:NUC
Nuchev Pty Ltd
0.09
-0.08
-46.88%
AU:NGS
Nutritional Growth Solutions Ltd.
0.02
>-0.01
-4.76%
AU:CLV
Clover Corporation Limited
0.95
0.40
73.99%

Australian Dairy Nutritionals Group Corporate Events

Australian Dairy Nutritionals boosts powder sales as China and Vietnam drive growth shift
Jul 30, 2026
Australian Dairy Nutritionals reported Q4 FY26 consolidated revenue of $2.6m, up 90% on the prior quarter but slightly down year on year, driven by strong growth in nutritional powder sales to $2.1m and expanding distribution of its Future brand i...
Australian Dairy Nutritionals Director Wenjun Zhang Steps Down, Retains Indirect Stake
Jul 10, 2026
Australian Dairy Nutritionals Group has announced that director Wenjun Zhang ceased to be a board member on 6 July 2026. The notice, lodged with the ASX, confirms that Zhang held no securities as a registered holder but had an indirect interest th...
Australian Dairy Nutritionals Adds New Director With No Current Shareholding
Jul 6, 2026
Australian Dairy Nutritionals Limited has appointed Daniel Espie as a director effective 6 July 2026, marking a change in the company&#8217;s board composition. According to the initial director&#8217;s interest notice lodged with the ASX, Espie c...
Australian Dairy Nutritionals reshapes board and appoints China-focused executive to drive growth
Jun 24, 2026
Australian Dairy Nutritionals Limited has reshaped its leadership team, appointing experienced food and dairy executive Daniel Espie as an independent non-executive director from 6 July 2026 and transitioning current non-executive director Wenjun ...
Australian Dairy Nutritionals Fast-Tracks Amended Long-Term Incentive Plan
Jun 16, 2026
Australian Dairy Nutritionals Limited has approved an amended Long Term Incentive Plan aimed at providing structured equity incentives to eligible participants and aligning their interests with shareholders. The plan is designed to support the com...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 18, 2026